Page last updated: 2024-08-07 16:23:27
Nitric oxide synthase, brain
A nitric oxide synthase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P29475]
Synonyms
EC 1.14.13.39;
Constitutive NOS;
NC-NOS;
NOS type I;
Neuronal NOS;
N-NOS;
nNOS;
Peptidyl-cysteine S-nitrosylase NOS1;
bNOS
Research
Bioassay Publications (35)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (14.29) | 18.2507 |
2000's | 23 (65.71) | 29.6817 |
2010's | 5 (14.29) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Compounds (45)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
imidazole | Homo sapiens (human) | Ki | 175.0000 | 1 | 1 |
s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea | Homo sapiens (human) | Ki | 0.0160 | 1 | 1 |
n-(3-(aminomethyl)benzyl)acetamidine | Homo sapiens (human) | IC50 | 4.8900 | 2 | 2 |
n-(3-(aminomethyl)benzyl)acetamidine | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
2-amino-4-picoline | Homo sapiens (human) | IC50 | 0.1407 | 5 | 7 |
3-bromo-7-nitroindazole | Homo sapiens (human) | IC50 | 0.1700 | 1 | 1 |
7-nitroindazole | Homo sapiens (human) | IC50 | 2.0267 | 3 | 3 |
beta-aminoethyl isothiourea | Homo sapiens (human) | Ki | 1.8000 | 1 | 1 |
pimagedine | Homo sapiens (human) | IC50 | 61.9500 | 2 | 2 |
pimagedine | Homo sapiens (human) | Ki | 3.3000 | 1 | 1 |
2-aminothiazole | Homo sapiens (human) | Ki | 12.0000 | 1 | 1 |
s-ethyl n-(4-(trifluoromethyl)phenyl)isothiourea | Homo sapiens (human) | Ki | 0.3200 | 1 | 1 |
etiron | Homo sapiens (human) | Ki | 0.0290 | 1 | 1 |
s-methylisothiopseudouronium | Homo sapiens (human) | Ki | 0.1600 | 1 | 1 |
indazoles | Homo sapiens (human) | IC50 | 178.0000 | 1 | 1 |
citrulline | Homo sapiens (human) | Ki | 2,350.0000 | 1 | 2 |
alpha-aminopyridine | Homo sapiens (human) | IC50 | 6.0000 | 2 | 2 |
2-amino-3-methylpyridine | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
2-aminothiazoline | Homo sapiens (human) | IC50 | 1.8000 | 1 | 1 |
2-aminothiazoline | Homo sapiens (human) | Ki | 0.4100 | 1 | 1 |
5-nitroindazole | Homo sapiens (human) | IC50 | 47.0000 | 1 | 1 |
6-nitroindazole | Homo sapiens (human) | IC50 | 32.0000 | 1 | 1 |
ng-nitroarginine methyl ester | Homo sapiens (human) | IC50 | 1.1167 | 3 | 3 |
n-(4-nitrophenacyl)imidazole | Homo sapiens (human) | Ki | 105.0000 | 1 | 1 |
1-aminoisoquinoline | Homo sapiens (human) | IC50 | 6.6000 | 1 | 1 |
6-aminoindazole | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
1-phenylimidazole | Homo sapiens (human) | Ki | 430.0000 | 1 | 1 |
3-indazolinone | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
5-aminoindazole | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
3,5-dimethylpyrazole-1-carboxamidine | Homo sapiens (human) | Ki | 350.0000 | 1 | 1 |
s-methylthiocitrulline | Homo sapiens (human) | IC50 | 0.0600 | 1 | 1 |
s-methylthiocitrulline | Homo sapiens (human) | Ki | 0.0500 | 1 | 1 |
n(g)-iminoethylornithine | Homo sapiens (human) | IC50 | 9.0000 | 1 | 1 |
n(g)-iminoethylornithine | Homo sapiens (human) | Ki | 331.1333 | 2 | 3 |
n,n-dimethylarginine | Homo sapiens (human) | Ki | 0.7000 | 1 | 1 |
omega-n-methylarginine | Homo sapiens (human) | IC50 | 3.3983 | 6 | 6 |
omega-n-methylarginine | Homo sapiens (human) | Ki | 503.9733 | 2 | 6 |
ng-nitroarginine methyl ester | Homo sapiens (human) | IC50 | 0.6900 | 1 | 1 |
delta-n-methylarginine | Homo sapiens (human) | IC50 | 5,005.0000 | 2 | 2 |
2-amino-5,6-dihydro-4h-1,3-thiazine | Homo sapiens (human) | IC50 | 3.2000 | 1 | 1 |
2-amino-5-methylthiazole | Homo sapiens (human) | Ki | 1.1000 | 1 | 1 |
nitroarginine | Homo sapiens (human) | IC50 | 1.2650 | 4 | 4 |
nitroarginine | Homo sapiens (human) | Ki | 0.2575 | 2 | 2 |
vinyl-l-nio | Homo sapiens (human) | Ki | 0.1000 | 1 | 1 |
arl 17477 | Homo sapiens (human) | IC50 | 0.0350 | 1 | 1 |
n(6)-(1-iminoethyl)lysine | Homo sapiens (human) | IC50 | 28.1160 | 10 | 10 |
pyrazole-1-carboxamidine | Homo sapiens (human) | Ki | 0.4000 | 1 | 1 |
gw 274150 | Homo sapiens (human) | IC50 | 92.1888 | 5 | 5 |
1-(4-(3-bromophenoxy)butyl)-1h-imidazole | Homo sapiens (human) | Ki | 60.0000 | 1 | 1 |
6-hydroxymethylpterin | Homo sapiens (human) | IC50 | 180.0000 | 1 | 1 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
sapropterin | Homo sapiens (human) | Kd | 1.1200 | 1 | 1 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
7-nitroindazole | Homo sapiens (human) | Inhibition | 15.0000 | 1 | 1 |
arginine | Homo sapiens (human) | Activity | 14.5000 | 1 | 1 |
[no title available]Journal of medicinal chemistry, , 06-10, Volume: 64, Issue:11, 2021
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation.ACS medicinal chemistry letters, , Jul-09, Volume: 11, Issue:7, 2020
Recent developments in fragment-based drug discovery.Journal of medicinal chemistry, , Jul-10, Volume: 51, Issue:13, 2008
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.Nature chemical biology, , Volume: 4, Issue:11, 2008
Structure-activity relationships of potent, selective inhibitors of neuronal nitric oxide synthase based on the 6-phenyl-2-aminopyridine structure.Journal of medicinal chemistry, , Mar-11, Volume: 47, Issue:6, 2004
2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution.Journal of medicinal chemistry, , Jun-03, Volume: 47, Issue:12, 2004
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.Bioorganic & medicinal chemistry letters, , Sep-04, Volume: 10, Issue:17, 2000
Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation.Bioorganic & medicinal chemistry, , Sep-01, Volume: 17, Issue:17, 2009
New 2-bromomethyl-8-substituted-benzo[c]chromen-6-ones. Synthesis and biological properties.Bioorganic & medicinal chemistry letters, , Jan-03, Volume: 15, Issue:1, 2005
Structure-activity relationships of potent, selective inhibitors of neuronal nitric oxide synthase based on the 6-phenyl-2-aminopyridine structure.Journal of medicinal chemistry, , Mar-11, Volume: 47, Issue:6, 2004
A new class of selective and potent inhibitors of neuronal nitric oxide synthase.Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 9, Issue:17, 1999
Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase.Bioorganic & medicinal chemistry, , Jun-01, Volume: 16, Issue:11, 2008
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.Journal of medicinal chemistry, , Mar-13, Volume: 46, Issue:6, 2003
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.Bioorganic & medicinal chemistry letters, , Sep-04, Volume: 10, Issue:17, 2000
L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.Journal of medicinal chemistry, , Jul-23, Volume: 52, Issue:14, 2009
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.Bioorganic & medicinal chemistry letters, , Sep-04, Volume: 10, Issue:17, 2000
Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase.Bioorganic & medicinal chemistry, , Jun-01, Volume: 16, Issue:11, 2008
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 14, Issue:17, 2004
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.Journal of medicinal chemistry, , Mar-13, Volume: 46, Issue:6, 2003
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors.Bioorganic & medicinal chemistry letters, , Jun-16, Volume: 13, Issue:12, 2003
Dihydroquinolines as novel n-NOS inhibitors.Bioorganic & medicinal chemistry letters, , Sep-16, Volume: 12, Issue:18, 2002
Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.Biochemistry, , Sep-15, Volume: 48, Issue:36, 2009
Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes.Bioorganic & medicinal chemistry letters, , Jun-02, Volume: 15, Issue:11, 2005
Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.Biochemistry, , Sep-15, Volume: 48, Issue:36, 2009
Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase.Bioorganic & medicinal chemistry, , Jun-01, Volume: 16, Issue:11, 2008
Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes.Bioorganic & medicinal chemistry letters, , Jun-02, Volume: 15, Issue:11, 2005
1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a pJournal of medicinal chemistry, , Mar-22, Volume: 55, Issue:6, 2012
NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity.ACS medicinal chemistry letters, , Mar-08, Volume: 3, Issue:3, 2012
Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.Biochemistry, , Sep-15, Volume: 48, Issue:36, 2009
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors.Bioorganic & medicinal chemistry letters, , Jun-16, Volume: 13, Issue:12, 2003
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.Bioorganic & medicinal chemistry letters, , Sep-04, Volume: 10, Issue:17, 2000
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine.Bioorganic & medicinal chemistry letters, , Mar-20, Volume: 10, Issue:6, 2000
N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.Journal of medicinal chemistry, , Jul-16, Volume: 41, Issue:15, 1998
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.Journal of medicinal chemistry, , Sep-10, Volume: 41, Issue:19, 1998
N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system.Bioorganic & medicinal chemistry, , Mar-01, Volume: 16, Issue:5, 2008
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms.Journal of medicinal chemistry, , Feb-02, Volume: 39, Issue:3, 1996
L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.Journal of medicinal chemistry, , Jul-23, Volume: 52, Issue:14, 2009
Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase.Bioorganic & medicinal chemistry, , Jun-01, Volume: 16, Issue:11, 2008
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors.Bioorganic & medicinal chemistry letters, , Jun-16, Volume: 13, Issue:12, 2003
Dihydroquinolines as novel n-NOS inhibitors.Bioorganic & medicinal chemistry letters, , Sep-16, Volume: 12, Issue:18, 2002
N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.Journal of medicinal chemistry, , Jul-16, Volume: 41, Issue:15, 1998
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.Journal of medicinal chemistry, , Sep-10, Volume: 41, Issue:19, 1998
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 21, Issue:14, 2011
Discovery of a series of aminopiperidines as novel iNOS inhibitors.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 18, Issue:1, 2008
2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution.Journal of medicinal chemistry, , Jun-03, Volume: 47, Issue:12, 2004
5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors.Journal of medicinal chemistry, , Feb-12, Volume: 47, Issue:4, 2004
Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases.Bioorganic & medicinal chemistry letters, , Dec-06, Volume: 14, Issue:23, 2004
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 14, Issue:17, 2004
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.Journal of medicinal chemistry, , Mar-13, Volume: 46, Issue:6, 2003
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.Bioorganic & medicinal chemistry letters, , Sep-04, Volume: 10, Issue:17, 2000
Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase.Journal of medicinal chemistry, , Mar-12, Volume: 41, Issue:6, 1998
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms.Journal of medicinal chemistry, , Feb-02, Volume: 39, Issue:3, 1996
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.Bioorganic & medicinal chemistry letters, , May-15, Volume: 21, Issue:10, 2011
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 21, Issue:14, 2011
Discovery of a series of aminopiperidines as novel iNOS inhibitors.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 18, Issue:1, 2008
2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution.Journal of medicinal chemistry, , Jun-03, Volume: 47, Issue:12, 2004
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine.Bioorganic & medicinal chemistry letters, , Mar-20, Volume: 10, Issue:6, 2000
Enables
This protein enables 15 target(s):
Target | Category | Definition |
nitric-oxide synthase activity | molecular function | Catalysis of the reaction: L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+. [EC:1.14.13.39, RHEA:19897] |
calcium channel regulator activity | molecular function | Modulates the activity of a calcium channel. [GOC:mah] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
calmodulin binding | molecular function | Binding to calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states. [GOC:krc] |
FMN binding | molecular function | Binding to flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes. [GOC:tb] |
sodium channel regulator activity | molecular function | Binds to and modulates the activity of a sodium channel. [GOC:mah] |
heme binding | molecular function | Binding to a heme, a compound composed of iron complexed in a porphyrin (tetrapyrrole) ring. [GOC:ai] |
tetrahydrobiopterin binding | molecular function | Binding to a tetrahydrobiopterin, 5,6,7,8-tetrahydrobiopterin or a derivative thereof; tetrahydrobiopterins are enzyme cofactors that carry electrons in redox reactions. [GOC:BHF, GOC:mah, GOC:rl] |
arginine binding | molecular function | Binding to 2-amino-5-(carbamimidamido)pentanoic acid. [GOC:BHF, GOC:rl] |
transmembrane transporter binding | molecular function | Binding to a transmembrane transporter, a protein or protein complex that enables the transfer of a substance, usually a specific substance or a group of related substances, from one side of a membrane to the other. [GOC:BHF, GOC:jl, PMID:33199372] |
cadmium ion binding | molecular function | Binding to a cadmium ion (Cd). [GOC:ai] |
calcium-dependent protein binding | molecular function | Binding to a protein or protein complex in the presence of calcium. [GOC:jid, PMID:10485905] |
flavin adenine dinucleotide binding | molecular function | Binding to FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2. [GOC:ai, GOC:imk, ISBN:0198506732] |
NADP binding | molecular function | Binding to nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH. [GOC:ai] |
scaffold protein binding | molecular function | Binding to a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes. [GOC:BHF, GOC:sjp, PMID:10433269, Wikipedia:Scaffold_protein] |
Located In
This protein is located in 14 target(s):
Target | Category | Definition |
photoreceptor inner segment | cellular component | The inner segment of a vertebrate photoreceptor containing mitochondria, ribosomes and membranes where opsin molecules are assembled and passed to be part of the outer segment discs. [GOC:add, PMID:12019563] |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
mitochondrion | cellular component | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. [GOC:giardia, ISBN:0198506732] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
cytoskeleton | cellular component | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. [GOC:mah, PMID:16959967, PMID:27419875] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
sarcoplasmic reticulum | cellular component | A fine reticular network of membrane-limited elements that pervades the sarcoplasm of a muscle cell; continuous over large portions of the cell and with the nuclear envelope; that part of the endoplasmic reticulum specialized for calcium release, uptake and storage. [GOC:mtg_muscle, ISBN:0124325653, ISBN:0198547684] |
sarcolemma | cellular component | The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers. [ISBN:0198506732] |
dendritic spine | cellular component | A small, membranous protrusion from a dendrite that forms a postsynaptic compartment, typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable:they can be thin, stubby, mushroom, or branched, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity. [GOC:nln] |
membrane raft | cellular component | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. [PMID:16645198, PMID:20044567] |
synapse | cellular component | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. [GOC:aruk, ISBN:0198506732, PMID:24619342, PMID:29383328, PMID:31998110] |
perinuclear region of cytoplasm | cellular component | Cytoplasm situated near, or occurring around, the nucleus. [GOC:jid] |
cell periphery | cellular component | The broad region around and including the plasma membrane of a cell, encompassing the cell cortex (inside the cell), the plasma membrane, and any external encapsulating structures. [GOC:pdt] |
Active In
This protein is active in 4 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
postsynaptic density | cellular component | An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components. [GOC:BHF, GOC:dos, GOC:ef, GOC:jid, GOC:pr, GOC:sjp, http://molneuro.kaist.ac.kr/psd, PMID:14532281, Wikipedia:Postsynaptic_density] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
protein-containing complex | cellular component | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. [GOC:dos, GOC:mah] |
Involved In
This protein is involved in 34 target(s):
Target | Category | Definition |
response to hypoxia | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. [GOC:hjd] |
regulation of sodium ion transport | biological process | Any process that modulates the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:dph] |
arginine catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid. [GOC:go_curators] |
nitric oxide biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. [GOC:ai] |
striated muscle contraction | biological process | A process in which force is generated within striated muscle tissue, resulting in the shortening of the muscle. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Striated muscle is a type of muscle in which the repeating units (sarcomeres) of the contractile myofibrils are arranged in registry throughout the cell, resulting in transverse or oblique striations observable at the level of the light microscope. [GOC:jl, GOC:mtg_muscle, ISBN:0198506732] |
myoblast fusion | biological process | A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers. [CL:0000056, GOC:mtg_muscle] |
response to heat | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. [GOC:lr] |
negative regulation of calcium ion transport into cytosol | biological process | Any process that decreases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components. [GOC:dph, GOC:tb] |
regulation of cardiac muscle contraction by calcium ion signaling | biological process | Any process that modulates the frequency, rate or extent of cardiac muscle contraction by changing the calcium ion signals that trigger contraction. [GOC:BHF, GOC:dph, GOC:tb] |
peptidyl-cysteine S-nitrosylation | biological process | The covalent addition of a nitric oxide (NO) group to the sulphur (S) atom of a cysteine residue in a protein, to form peptidyl-S-nitrosyl-L-cysteine. [RESID:AA0230] |
positive regulation of peptidyl-serine phosphorylation | biological process | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. [GOC:mah] |
multicellular organismal response to stress | biological process | Any process that results in a change in state or activity of a multicellular organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation). [GOC:mah] |
xenobiotic catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of a xenobiotic compound, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. [GOC:jl, GOC:krc] |
vasodilation | biological process | An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure. [GOC:pr, ISBN:0192800981] |
negative regulation of potassium ion transport | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:jl] |
cell redox homeostasis | biological process | Any process that maintains the redox environment of a cell or compartment within a cell. [GOC:ai, GOC:dph, GOC:tb] |
positive regulation of DNA-templated transcription | biological process | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
positive regulation of transcription by RNA polymerase II | biological process | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. [GOC:go_curators, GOC:txnOH] |
negative regulation of hydrolase activity | biological process | Any process that stops or reduces the rate of hydrolase activity, the catalysis of the hydrolysis of various bonds. [GOC:ai] |
negative regulation of serotonin uptake | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of serotonin into a cell. [GOC:ai] |
negative regulation of calcium ion transport | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:ai] |
regulation of cardiac muscle contraction | biological process | Any process that modulates the frequency, rate or extent of cardiac muscle contraction. [GOC:ecd] |
regulation of ryanodine-sensitive calcium-release channel activity | biological process | Any process that modulates the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts. [GOC:BHF, GOC:dph, GOC:tb] |
cellular response to growth factor stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. [GOC:mah] |
positive regulation of the force of heart contraction | biological process | Any process that increases the force of heart muscle contraction. [GOC:BHF, GOC:dos, GOC:mtg_cardiac_conduct_nov11, GOC:rl, PMID:17242280] |
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | biological process | Any process that activates or increases the frequency, rate or extent of an adenylate cyclase-activating G protein-coupled receptor signaling pathway. [GOC:hjd, PMID:19246489] |
positive regulation of sodium ion transmembrane transport | biological process | Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transport. [GOC:BHF, GOC:mtg_cardiac_conduct_nov11, GOC:rl, GOC:TermGenie, PMID:18591664] |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | biological process | Any process that modulates the frequency, rate or extent of generation of calcium ion transmembrane transport via high voltage-gated calcium channel. [GOC:dph, GOC:pg, GOC:TermGenie, PMID:1611048] |
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential | biological process | Any process that activates or increases the frequency, rate or extent of membrane repolarization during ventricular cardiac muscle cell action potential. [GO_REF:0000058, GOC:BHF, GOC:BHF_miRNA, GOC:mtg_cardiac_conduct_nov11, GOC:rph, GOC:TermGenie, PMID:19893015] |
positive regulation of guanylate cyclase activity | biological process | Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity. [GOC:mah] |
nitric oxide mediated signal transduction | biological process | An intracellular signaling cassette that starts with production of nitric oxide, detection by receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and ends with the activation of downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms. [GOC:jl, PMID:21549190] |
response to hormone | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus. [GOC:jl] |
negative regulation of blood pressure | biological process | Any process in which the force of blood traveling through the circulatory system is decreased. [GOC:go_curators, GOC:mtg_cardio] |
response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:add, ISBN:0721601464] |